AzTrials
AzTrials

Social Stigma Towards People With AddictionSASNCT06705205

Short, Animated Storytelling (SAS) for Addiction Stigma Reduction

A study testing SAS video in people with Social Stigma Towards People With Addiction, run by Stanford University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Stigma towards people with addiction is a well-documented problem that negatively impacts help-seeking, treatment and recovery. Social contact with people recovering from addiction can promote empathy and reduce stigma, but social contact is difficult to scale. Read more about this study

Who is it for?
Ages 18 to 49 yearsHealthy volunteers can take part
What is being tested?
SAS video
Could I receive a placebo?
No, everyone receives an active treatment
How many people
13,397 participants
Where
1 siteUnited States
Study dates
3 Jul 2025to 22 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 49 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adults with basic English proficiency between the ages of 18-49

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Stanford University

    Stanford, California, 95305

Other trials in United States

About this study

Official title: Short, Animated Storytelling Video to Reduce Addiction Stigma: Protocol for a Multi-country, Online, Randomized, Controlled Trial With 13,500 Participants

Stigma towards people with addiction is a well-documented problem that negatively impacts help-seeking, treatment and recovery. Social contact with people recovering from addiction can promote empathy and reduce stigma, but social contact is difficult to scale. Short, animated storytelling (SAS) is a novel health communication approach that scales easily because it can leapfrog barriers associated with language, culture, literacy and education levels. This study will investigate if a SAS video intervention can be used to reduce stigma, boost optimism and hope, and increasing empathy towards people with addiction. The study will also explore mechanisms of action of SAS interventions, by measuring the contribution of sound design to the effect of the intervention.

Being tested
SAS video

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SAS videoOther

    Also called short animated storytelling video

    The intervention is a short, animated storytelling video, with soundtrack, aimed at reducing addiction stigma.

Study groups in NCT06705205
Study groupRoleWhat they receive
SAS video full intervention groupExperimentalParticipants view the full SAS video intervention with sound on Day 1.
Receives: Other: SAS video
SAS video partial intervention (without sound)ExperimentalParticipants view the partial SAS video intervention without sound on Day 1.
Receives: Other: SAS video
Active Control GroupNo interventionParticipants read written information about addiction prevalence

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Addiction Stigma Scale Score as measured by the Attribution Questionnaire (AQ)

    Participants complete an 18-item shortened version of the validated AQ. The AQ-18 will be scored along a 9-point Likert scale indicating the extent to which participants agree with the item ranging from "not at all" to "very much" with a maximum score of 27 for each 3-item construct. Higher scores indicate greater stigma.

    Measured: Immediately post-intervention on Day 1 and after two weeks

Secondary outcomes (3)
  1. Change in Optimism Scale Score

    Participants complete the Brief García's Interactive Optimism Scale (BIOS-G). The BIOS-G is an instrument designed to assess an individual's level of general optimism towards their life and other people. The scale includes 4 statements for which respondents indicate their level of agreement from 1 ("Of course not") to 4 ("Yes, of course"). Higher scores indicate a greater level of optimism.

    Measured: Immediately post-intervention on Day 1 and after two weeks

  2. Change in Attitude Thermometer Score

    Participants will indicate their warmth towards subject using a self-report stigma thermometer. Using a scale scores from zero to 100, with higher scores indicating more empathy or more favorable attitudes.

    Measured: Immediately post-intervention on Day 1 and after two weeks

  3. Change in Levels of Hope using a visual analogue scale (VAS)

    Participants self-report levels of hope using a VAS, a longstanding, validated tool for assessing related constructs of stress and subjective well-being. The scale goes from zero to 100 and higher scores indicate higher levels of hope.

    Measured: Immediately post-intervention on Day 1 and after two weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2024
  2. Study start3 Jul 2025
  3. Primary completion22 Aug 2025
  4. Study completion22 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
13,397 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06705205
Sponsor's protocol ID
76457
Acronym
SAS
Status last verified
Sep 2025
First submitted
22 Nov 2024
Last updated
3 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All data will be made available via the Stanford Medicine Research Repository.

Publications

  • Adam M, Rohr JK, Greuel M, Seeff M, Margulis E, Gates J, Klapow M, Liu S, Amsalem D, Barnighausen T. Short, animated storytelling social contact videos reduce addiction stigma in the UK, USA, and South Africa: a randomised controlled trial of 13,397 participants. EClinicalMedicine. 2026 Aug 19;99:104129. doi: 10.1016/j.eclinm.2026.104129. eCollection 2026 Sep.

    PubMed 42802839
  • Adam M, Klapow M, Greuel M, Seeff M, Rohr JK, Gordon A, Amsalem D, Barnighausen T. Short, Animated Storytelling Video to Reduce Addiction Stigma in 13,500 Participants Across Multiple Countries Through an Online Approach: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 May 5;14:e73382. doi: 10.2196/73382.

    PubMed 40324168

Questions about this trial

What is this clinical trial studying?

A study testing SAS video in people with Social Stigma Towards People With Addiction, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Addiction Stigma Scale Score as measured by the Attribution Questionnaire (AQ) (time frame: Immediately post-intervention on Day 1 and after two weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06705205, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in